Opendata, web and dolomites

Calcivis CAIS

Validation of clinical performance and pre-commercial development of a novel diagnostic for dental caries assessment

Total Cost €


EC-Contrib. €






 Calcivis CAIS project word cloud

Explore the words cloud of the Calcivis CAIS project. It provides you a very rough idea of what is the project "Calcivis CAIS" about.

prognostic    ce    ions    demineralising    full    pilot    version    diagnostic    commercial    active    examination    fill    innovative    progress    launch    recombinant    market    decay    differentiation    photoprotein    off    switching    tooth    teeth    calcium    sophisticated    inactive    effectiveness    moving    drill    subject    visual    subjective    extracted    prototype    detect    dental    form    clinical    undergoing    unmet    performance    uniquely    mark    accelerate    tactile    prevention    first    cavitation    validation    proof    safety    dentistry    december    progression    device    preventive    validate    ongoing    unnecessarily    uses    automatic    leads    ready    away    enabled    demineralisation    calcivis    therapeutic    monitoring    incipient    detection    capability    clinic    marker    surface    gradually    caries    lesions    free    date    shift    paradigm    globally    imaging    diagnosis    differentiate    missed    granted    restored    actively    standards    2013   

Project "Calcivis CAIS" data sheet

The following table provides information about the project.


Organization address
address: 9 Edinburgh BioQuarter, Little France
city: Edinburgh
postcode: EH16 4UX
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website
 Total cost 2˙975˙531 €
 EC max contribution 2˙615˙000 € (88%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2017-06-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CALCIVIS LIMITED UK (Edinburgh) coordinator 2˙615˙000.00


 Project objective

The project will support development of the market ready version of the Calcivis Caries Activity Imaging System (currently in advanced prototype form) and validate its clinical performance against existing standards, which will enable first EU launch within one year of funding and US launch within two.

The Calcivis technology is a highly innovative and globally significant dental diagnostic which has the capability to enable and accelerate the ongoing paradigm shift towards preventive dentistry. Uniquely it uses a recombinant photoprotein marker and a sophisticated imaging device to detect free calcium ions at the tooth surface, to provide diagnostic and prognostic information on the development and progression of caries lesions (tooth decay).

There is a significant unmet need in dentistry to differentiate early caries lesions that are actively demineralising from those that are less likely to progress to cavitation. Current state of the art is subjective visual/tactile examination which leads to active lesions being missed and inactive lesions being unnecessarily restored. Dental practice is gradually moving towards diagnosis/prevention and away from automatic ‘drill and fill’ approaches; a shift which will be further enabled by the Calcivis System.

It is the only product that can directly detect ongoing demineralisation in the clinic which enables: - differentiation of active from inactive lesions - early detection of incipient active lesions - monitoring of therapeutic effectiveness i.e. ‘switching off’ of activity

To date, a prototype of the Calcivis System has been used to demonstrate proof of concept in extracted teeth and is now undergoing a pilot safety and performance clinical study. The clinical prototype was granted a CE mark in December 2013. The results of this clinical study and ongoing market research are being used to support design of the commercial device and the full clinical validation programme, which is the subject of this application.


List of deliverables.
Receipt acknowledged by FDA Documents, reports 2019-07-24 15:31:51
Ethics and NHS R+D approval letter received Documents, reports 2019-07-24 15:31:51
Clinical study 1 report (interim) completed and approved Documents, reports 2019-07-24 15:31:51

Take a look to the deliverables list in detail:  detailed list of Calcivis CAIS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CALCIVIS CAIS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CALCIVIS CAIS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  


Integrating and decentralising diabetes and hypertension services in Africa

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More